ValiRx receives US patent protection for exciting lead cancer drug

03:43 EDT 20 Mar 2018 | Proactive Investors

The protection covers the molecule and a “wide variety of derivatives, modifications and analogues of the compounds and their mode of action”

Original Article: ValiRx receives US patent protection for exciting lead cancer drug

NEXT ARTICLE

More From BioPortfolio on "ValiRx receives US patent protection for exciting lead cancer drug"